Browse Cases

Why It Matters: This motion presents a consequential and underexplored question about whether Section 230's immunity extends to evidentiary proceedings — specifically, whether the statute can be used to exclude testimony that would characterize a platform's internal decisions as publisher or editorial choices, potentially expanding Section 230's reach beyond its traditional role as a liability bar into a trial-stage evidentiary doctrine. The outcome could affect how government plaintiffs in the wave of state AG and AG-parallel cases against Meta are able to introduce internal evidence of platform design and moderation decisions at trial.

Why It Matters: This motion represents a notable and relatively rare invocation of Section 230 as a trial-stage evidentiary bar rather than a pleading-stage immunity defense, testing whether §230 can preclude entire categories of evidence concerning platform policy choices — a question with significant implications for how government enforcement actions against platforms can be litigated. The outcome could clarify the extent to which Section 230's publisher immunity principle constrains not just liability theories but the evidentiary record in public-enforcement cases brought by state attorneys general.

Why It Matters: These motions present a significant and relatively rare trial-stage application of Section 230 as an evidentiary bar in a state attorney general enforcement action, directly testing the scope of Section 230 immunity against failure-to-warn, misrepresentation, and unfair business practices claims premised on Meta's publishing decisions and platform design — an important front in the ongoing litigation over whether Section 230 shields platform design choices and moderation policies from state consumer protection enforcement.

Why It Matters: This filing sharpens three doctrinal pressure points simultaneously. First, by framing Meta's UX and algorithmic architecture as standalone liability-generating conduct divorced from the third-party content they deliver, the AGs are asking the court to draw — at summary judgment and as a matter of law — the line between immunized content-presentation choices and non-immunized product design that courts have struggled to locate since the *Instagram MDL* proceedings. Second, the COPPA actual-knowledge argument, if credited, would represent one of the first Article III holdings imposing COPPA liability on a major platform through litigation rather than consent decree, generating immediate pressure for circuit-level resolution. Third, the "directed to children" theory applied to a general-audience platform with heavy minor usership pushes the § 312.2 definition well beyond prior FTC enforcement targets, and if adopted, would effectively require any platform with substantial underage engagement to comply with COPPA's full consent regime regardless of marketing intent — a structural shift with industry-wide consequences.

Why It Matters: Meta's central defense at summary judgment is that Section 230 extinguishes the states' consumer protection claims before they can reach a jury, on the theory that those claims would effectively hold Meta liable as a publisher of harmful user-generated content. The Massachusetts Supreme Court — one of the most respected state courts of last resort in the country — just rejected that argument in a case involving the same defendant and a structurally similar legal theory, and Plaintiffs are placing that ruling before the MDL judge at the earliest opportunity. Whether it moves the needle depends on how closely the Massachusetts claims and pleadings track those at issue in the MDL, a question the filing conspicuously leaves unaddressed and that Meta will almost certainly contest. The filing also signals a deliberate multi-forum strategy by the state AGs: collecting appellate-level authority across jurisdictions to build persuasive momentum against Section 230 preemption — a campaign worth watching as similar litigation proceeds in other states.

Why It Matters: The opinion is the most prominent state appellate-court decision to date to categorically hold that Section 230 does not immunize platform design-defect or product-deception claims, and it does so through a textually grounded, common-law publisher framework that is methodologically distinct from — and directly contests — the reasoning this MDL court has previously applied. By naming and rejecting the MDL court's prior rulings, the SJC supplies a reasoned, appellate-level counter-analysis that, while not binding in federal court, materially reduces those rulings' persuasive authority and gives this Court a fully developed alternative framework to consider when resolving the pending motion. The procedural holding — that Section 230 immunity supports interlocutory appeal under the present-execution doctrine — also signals that state courts of last resort are prepared to treat Section 230 as a true immunity from suit, consistent with federal consensus but now carrying explicit state appellate endorsement. What remains open is whether this Court will credit the SJC's common-law publisher test over its own prior analysis, a question that will be resolved when it rules on Related Doc. 266.

Why It Matters: Meta's decision to introduce this transcript as its own exhibit while seeking to seal it is the central strategic puzzle: the company appears to be attempting to manage how damaging insider testimony enters the federal record rather than allowing plaintiffs to introduce it on their own terms and framing. The sealing request is legally vulnerable under *Kamakana v. City & County of Honolulu* because the testimony comes from an open state-court trial and carries a strong presumption of public access, particularly where the underlying MIL bears meaningfully on the scope of trial. If the court denies sealing and resolves the MIL against Meta, Boland's acknowledged combination of documented internal knowledge of predictable harm pathways, the suppression of that knowledge, and the direct revenue linkage to the contested algorithmic design could substantially strengthen plaintiffs' corporate-knowledge, concealment, and punitive damages theories across the MDL.

Why It Matters: Meta is attempting something more aggressive than a typical motion in limine: it wants a prior legal ruling that it cannot be held liable for certain features to also mean that witnesses cannot testify about those features at trial — the difference between a court saying "you cannot win on that theory" and saying "the jury cannot hear about it at all." If the court accepts this theory, it could substantially narrow the plaintiffs' trial presentation on core design-defect claims that survived the motion-to-dismiss stage, because the platform features at issue are the same ones underlying the surviving theories. No circuit court appears to have squarely endorsed using a Section 230 immunity ruling as a prospective evidentiary exclusion, making Judge Gonzalez Rogers's ruling on this question potentially the first of its kind in a major platform-liability MDL — and a significant marker for how Section 230 doctrine functions once a case reaches trial.

Why It Matters: Meta is asking the court to block, before trial begins, the evidentiary foundation the California AG would use to show that Meta's conduct was unreasonable — the equivalent of barring a products-liability plaintiff from presenting evidence that a safer design existed. If granted, even partially, this ruling would signal that Section 230 and the First Amendment can together preempt the expert toolkit in state government enforcement actions, with immediate consequences for every AG suit currently pending against social media platforms. The motion also advances a largely untested procedural theory: that Section 230 can function as an *in limine* evidentiary bar, not merely a pleading-stage immunity — a doctrinal expansion that no circuit has squarely endorsed. Judge Gonzalez Rogers's ruling will be closely watched as a potential bellwether on whether platforms can use constitutional and statutory shields to hollow out liability cases without ever reaching a merits trial.